04 February 2025
04 February 2025
Article doesn't exist
On World Cancer Day, tackling barriers in equitable cancer care requires not only policy action, but a shift in how cancer is examined.
The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.
The colorectal cancer mutation study is one of the first to be initiated under the FDA’s Project FrontRunner.
AdvanCell’s lead candidate ADVC001 is being evaluated in a Phase I/II dose escalation clinical trial.
Microplastics are an issue that we can’t continue to brush under the rug.
The recommendation is based on positive outcomes from the Phase III ADRIATIC trial.
Vanda will pay AnaptysBio $10m upfront along with $5m for the current drug supply.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
